FindTrial
Sign In

to study modified sphenopalatine ganglion block for pain relief in post dural puncture headache patients

A randomized, double-blind, placebo-controlled study to evaluate Modified sphenopalatine ganglion block for pain relief in PDPH patients. - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109702
Enrollment
40
Registered
2026-04-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: MODIFIED SPENOPALATINE GANGLION BLOCK: MSPGB the patients will be made to lie supine with neck extended and nostrils pointing in an upward direction. 2 ml of solution (1mL lignocaine A

Sponsors

sanjay gandhi post gradute institute of medical sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients aged 18 to 65 years presenting with typical features of PDPH following neuraxial blockade or accidental dural puncture were included in the trial

Exclusion criteria

Exclusion criteria: history of local anesthetic allergy, hostory of neuropsychiatric disorder

Design outcomes

Primary

MeasureTime frame
The primary outcome was pain severity, measured using the 11-point Numeric Rating Scale (0 = no pain; 10 = worst imaginable pain).Timepoint: The primary outcome was pain severity, measured using the 11-point Numeric Rating Scale (0 = no pain; 10 = worst imaginable pain).—

Secondary

MeasureTime frame
The secondary outcomes were the number of additional blocks required, patient satisfaction score and time to discharge.Timepoint: upto 72 hrs of surgery.—

Countries

India

Contacts

Public ContactAMIT RASTOGI

sanjay gandhi post graduate institute of medical sciences

amit.rastogi.sgpgi@gmail.com8765974043

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026